Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference27 articles.
1. Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications;McLean;Anesthesiology,2015
2. Introduction of sugammadex as standard reversal agent: impact on the incidence of residual neuromuscular blockade and postoperative patient outcome;Ledowski;Indian J Anaesth,2013
3. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships;Adam;J Med Chem,2002
4. Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation;Paton;Br J Anaesth,2010
5. Reversal of rocuronium-induced neuromuscular block by sugammadex in neonates: 10AP1-3;Alonso;Eur J Anaesthesiol,2014
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The safety and efficacy of sugammadex for reversing neuromuscular blockade in younger children and infants;Expert Opinion on Drug Safety;2024-07-02
2. Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade in Adults and Children: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Current Drug Safety;2024-02
3. Reversal of Rocuronium-Induced Neuromuscular Blockade by Sugammadex Under Sevoflurane and Desflurane Anesthesia in Children;The Eurasian Journal of Medicine;2023-10-26
4. Rocuronium-neuromuscular blockade does not influence the patient state index in anesthetized dogs;American Journal of Veterinary Research;2023-05-31
5. Comparative study between sugammedex and neostigmine as a reversal agent of rocuronium for pediatric patients 2-12 years old going for surgery under general anaesthesia;CARDIOMETRY;2023-05-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3